Canakinumab is licensed to treat certain types of rare genetic conditions called cryopyrin-associated periodic syndromes. It can also be used to treat a certain type of juvenile arthritis. This prescription medication comes in the form of an injection that is given just under the skin once every eight weeks. Potential side effects include diarrhea, nausea, and symptoms of the common cold.
What Is Canakinumab?
Canakinumab (Ilaris®) is a prescription medication approved to treat the following conditions:
- Rare genetic autoinflammatory conditions known as cryopyrin-associated periodic syndromes (CAPS), such as:
- Familial cold autoinflammatory syndrome (FCAS)
- Muckle-Wells syndrome (MWS)
- Systemic juvenile idiopathic arthritis (SJIA).
It belongs to a group of medicines known as monoclonal antibodies.
(Click What Is Canakinumab Used For? for more information on this topic, including possible off-label uses.)
Are There Side Effects?Just like any medicine, canakinumab may cause side effects. However, not everyone who receives the drug will experience problems. In fact, most people tolerate it quite well. If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
Common side effects seen with canakinumab include but are not limited to:
(Click Canakinumab Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)